| Literature DB >> 31640994 |
Esther Hobson1,2, Wendy Baird3, Mike Bradburn4, Cindy Cooper4, Susan Mawson3, Ann Quinn5, Pamela J Shaw6,2, Theresa Walsh6,2, Christopher J McDermott6,2.
Abstract
OBJECTIVES: To evaluate the processes involved in using a novel digitally enabled healthcare system (telehealth in motor neuron disease (TiM)) in people living with motor neuron disease (MND) and their informal carers. We examined TiM implementation, potential mechanisms of impact and contextual factors that might influence TiM implementation or impact.Entities:
Keywords: amyotrophic lateral sclerosis; motor neuron disease; process evaluation; qualitative; telehealth; telemedicine
Mesh:
Year: 2019 PMID: 31640994 PMCID: PMC6830641 DOI: 10.1136/bmjopen-2018-028526
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Participant characteristics
| Telehealth (n=20) | Control (n=20) | |
| Patient gender, male | 14 (70%) | 14 (70%) |
| Age (years) | 60.4 (11.7), 30–78 | 60.0 (10.0), 39–73 |
| Disease duration (months) | 53 (48), 12–197 | 46 (35), 7–123 |
| King’s ALS clinical stage* | ||
| 1 | 3 (15%) | 2 (10%) |
| 2 | 4 (20%) | 5 (25%) |
| 3 | 5 (25%) | 8 (40%) |
| 4 | 8 (40%) | 5 (25%) |
| Use of the TiM app | ||
| Independently | 17 (85%) | 17 (85%) |
| Help from carer | 1 (5%) | 1 (5%) |
| Patient instructs carer | 2 (10%) | 2 (15%) |
| Patient technology use† | ||
| Daily | 14 (70%) | 18 (90%) |
| Few times per week | 3 (15%) | 1 (5%) |
| Once a week | 1 (5%) | 1 (5%) |
| Every few weeks | 0 (0%) | 0 (0%) |
| Never | 2 (10%) | 0 (0%) |
*King’s stage 1 refers to patients with functional deficit in one domain, stage 2 refers to disability in two domains, stage 3 refers to disability in three domains and stage 4 refers to patients requiring NIV and/or gastrostomy. King’s stage was calculated using the ALS-FRS-R scale at baseline.
†Technology use: computer, tablet, smart phone.
ALS-FRS-R, Amytrophic lateral sclerosis functional rating scale revised; NIV, Non-invasive ventilation; TiM, telehealth in motor neuron disease.
Technology problems encountered during the trial
| Problem | Solution adopted | Impact on the use of the TiM | Recommendations for future TiM use |
| TiM Patient App software | |||
| Poor finger dexterity | Handheld stylus provided | 85% used TiM independently. | Provide stylus to all patients. |
| Carer help to use device | Interview data suggested that help from carers was acceptable. | Encourage carer support. | |
| Difficulties entering login password | Telephone support | Problem resolved with second TiM app release. | Provide face-to-face training. |
| Login page redesigned | No further problems reported. | Make local staff familiar with the software. | |
| Lack of confidence using the app or other features on the TiM | Face-to-face training | None: all participants could use the app. | Provide face-to-face training plus an additional contact after a few weeks to reinforce learning. Identify low confidence/experience users and provide extra training. |
| Patients not giving correct answers | Patient completing TiM with their family | Uncertain impact. | Capacity assessment at recruitment. Check TiM answers in training and in clinic. |
| Tablet | |||
| Tablet stored in place not accessible to patient | No solution available | Interviews suggested that adherence was reduced for two patients. | Use patients’ own equipment where possible. |
| Tablet battery drained, unable to switch on | Telephone advice | No impact. | Use patients’ own equipment. Familiarise local staff with hardware. |
| Unexpected screens/ software updates | Telephone advice | Reduced user confidence in tablet but no impact on use. | Use patients’ own equipment. Use a basic tablet that only displays the TiM app. |
| User fear of ‘breaking’ the tablet | Face-to-face training to improve user confidence | Patients/carers reluctant to use the additional features on the tablet. | Use patients’ own equipment. |
| Internet connection | |||
| Poor 3G phone signal | Used patients’ own broadband | None: solution found for all patients (3G or patients’ own broadband) | Use patients’ own broadband. Check internet availability prior to TiM enrolment. |
| Patients switched Wi-Fi off | Home visit required | Several TiM sessions failed to download. | Monitor adherence. Alert team if adherence is low. |
| Unreliable connection between scales and tablet/broadband | A separate 3G Wi-Fi route provided (‘Mifi’). No solution if using broadband | Additional home visits required and loss of weight data for several weeks. | Manual weight recording. Avoid using peripheral devices. |
| Clinician portal | |||
| Password/login problems | Support by external IT team | Delayed access during MDC visit. | Local systems access support. |
MDC, multidisciplinary clinic; TiM, telehealth in motor neuron disease.
Figure 1Patient and carer satisfaction with TiM telehealth at 6 months. MND, motor neuron disease; TiM, telehealth in motor neuron disease.
Figure 4The ‘heat map’ for Patient 409. This is a screenshot from the clinical portal. The heat map reports the highest level flag for each section of the questionnaire (mobility, bulbar, breathing, well-being, nutrition) at each week. This indicates the patient has red and amber flags for both bulbar and later mobility. Below is the weight compared with the patients’ weight at baseline demonstrating a greater than 15% weight loss.
Figure 5(A) (left) The frequency of flags generated by the TiM sessions. The total sessions report the frequency of ‘top level’ flag (green, amber, red) for all 585 sessions completed. Below are the frequencies of ‘section flags’ generated by 10 patients who completed a total of 334 sessions. (B) (right) Actions described in 99 clinical notes. C, carer; MDT, multidisciplinary team; P, patient; TiM, telehealth in motor neuron disease; TN, telehealth nurse.